President Donald Trump on Saturday directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine, which recently has been embraced by combat veterans and conservative lawmakers despite having serious safety risks.

The president will direct federal agencies to boost research into the drugs and support clinical trials, moves championed by Robert F. Kennedy Jr.

President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs." "These treatments are currently in the advanced stages of clinical trials to ensure that they're both safe and effective for the American patients,

President Donald Trump announced new efforts to boost research into psychedelic drugs and make them available in controlled environments.

Trump signed an executive order directing federal regulators to accelerate the review of certain psychedelic drugs.

Trump has announced a drug policy reform to ease restrictions on psychedelics to support veterans' mental health treatment.

President Trump is expected to sign an executive order that would open the door to federal funding for research into the psychedelic ibogaine.

President Trump on Saturday signed an executive order to expedite research into the psychedelic ibogaine – a drug championed by podcaster Joe Rogan – so it can be used to treat PTSD in veterans and traumatic brain injuries.